Turn EHA data into business-critical insights. 30 high-prescribing hem/oncs analyze 10 Acute Myeloid Leukemia abstracts to help you prepare for what’s next. Take the guesswork out of understanding changes in prescribing behavior for: azacitidine, enasidenib, gilteritinib, sabatolimab, and venetoclax among others. Get your 60+ slide report.

Acute Myeloid Leukemia Report EHA 2021

European Hematology Association

Virtual Meeting
Jun 9 to Jun 17

Share: